10-3-2815 US purchaser questionnaire

OMB No. 3117-0016/USITC No. 10-3-2815; Expiration Date: 6/30/2011
(No response is required if currently valid OMB control number is not displayed)

U.S. PURCHASERS’ QUESTIONNAIRE
CLOROPICRIN FROM CHINA

This questionnaire must be received by the Commission by no later than DECEMBER 16, 2009
See page 4 of the Instruction Booklet for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its review of the antidumping duty order concerning chloropicrin from China (inv. No. 731-TA-130
(Review)). The information requested in the questionnaire is requested under the authority of the Tariff Act of 1930, title
VII. This report is mandatory and failure to reply as directed can result in a subpoena or other order to compel
the submission of records or information in your possession (19 U.S.C. § 1333(a)).

Name of firm
Address
State

City

Zip Code

World Wide Web address
Has your firm purchased chloropicrin (as defined in the instruction booklet) from any source (domestic or
foreign) at any time since January 1, 2006?

NO

(Sign the certification below and promptly return only this page of the questionnaire to the Commission)

YES

(Read the instruction booklet carefully, complete all parts of the questionnaire, and return the entire
questionnaire to the Commission so as to be received by the date indicated above)

CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my knowledge
and belief and understand that the information submitted is subject to audit and verification by the Commission.
By means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout this review in any other import-injury investigations or reviews
conducted by the Commission on the same or similar merchandise.
I acknowledge that information submitted in this questionnaire response and throughout this review may be used by the
Commission, its employees, and contract personnel who are acting in the capacity of Commission employees, for developing or
maintaining the records of this review or related proceedings for which this information is submitted, or in internal audits and
investigations relating to the programs and operations of the Commission pursuant to 5 U.S.C. Appendix 3. I understand that all
contract personnel will sign non-disclosure agreements.

Name of Authorized Official

Title of Authorized Official
Phone: (

Date

)

Signature

E-mail address
Fax (

)

Business Proprietary
U.S. Purchasers’ Questionnaire – Chloropicrin from China (731-TA-130 (Third Review))

Page 2

PART I.—GENERAL INFORMATION
The questions in this questionnaire have been reviewed with market participants to ensure that issues of
concern are adequately addressed and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to average 40 hours per response,
including the time for reviewing instructions, searching existing data sources, gathering the data needed,
and completing and reviewing the questionnaire. Send comments regarding the accuracy of this burden
estimate or any other aspect of this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade Commission, 500 E Street, SW,
Washington, DC 20436.
I-1a.

OMB statistics.--Please report below the actual number of hours required and the cost to your
firm of preparing the reply to this questionnaire and completing the form.
hours

dollars

I-1b.

OMB feedback.--We are interested in any comments you may have for improving this
questionnaire in general or the clarity of specific questions. Please attach such comments to your
response or send them to the above address.

I-2.

Establishments covered.--Provide the name and address of establishment(s) covered by this
questionnaire (see page 3 of the instruction booklet for reporting guidelines). If your firm is
publicly traded, please specify the stock exchange and trading symbol.

I-3.

Ownership.--Is your firm owned, in whole or in part, by any other firm?

I-4.

No

Yes--List the following information.

Firm name

Address

Extent of
ownership

Related SUBJECT importers/exporters.--Does your firm have any related firms, either
domestic or foreign, which are engaged in importing chloropicrin from China into the United
States or which are engaged in exporting chloropicrin from China to the United States?
No

Yes--List the following information.

Firm name

Address

Affiliation

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 3

PART I.--GENERAL INFORMATION--Continued
I-5.

Related NONSUBJECT importers/exporters.--Does your firm have any related firms, either
domestic or foreign, which are engaged in importing chloropicrin from countries other than China
into the United States or which are engaged in exporting chloropicrin from countries other than
China to the United States?
No

Yes--List the following information.

Firm name and country

I-6.

I-7.

Address

Affiliation

Related producers.--Does your firm have any related firms, either domestic or foreign, which
are engaged in the production of chloropicrin?
No

Yes--List the following information.

Firm name

Address

Affiliation

Business plan.--In Parts II and III of this questionnaire we request a copy of your company’s
business plan. Does your company or any related firm have a business plan or any internal
documents that describe, discuss, or analyze expected market conditions for chloropicrin?
No

Yes--Please provide the requested documents. If you are not providing the
requested documents, please explain why not.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 4

PART II.--PURCHASES AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Joshua Levy (202-205-3236,
joshua.levy@usitc.gov). Supply all data requested on a calendar-year basis.
II-1.

Contact information (Purchases).--Who should be contacted regarding the requested trade and
related information?
Company contact:
Name and title
(
)
Phone number

II-2.

E-mail address

Purchases.--Report, as indicated below, your firm’s purchases (either directly or through a sales
agent or broker) of chloropicrin. Report based on delivery date, not order date.

Quantity (in pounds) and value (in $1,000)
Item
2006
Purchases of chloropicrin produced in-The United States:
Quantity
Value
China:
Quantity
Value
All other countries:1
Quantity
Value
1
Please identify these countries:

2007

2008

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 5

PART II.--TRADE AND RELATED INFORMATION--Continued
II-3.

Purchases before and after order.-(a)

Did your firm purchase chloropicrin from China before 2006?
No--skip to (c)

(b)

Yes

If yes, has your pattern of purchasing chloropicrin from China changed since 2006?
No, our pattern of purchasing is essentially unchanged.
Yes, we discontinued purchases from China because of the order.
Yes, we reduced purchases from China because of the order.
Yes, but we changed the pattern of purchases from China for reasons other than the
order (please explain below).

(c)

Has your pattern of purchasing chloropicrin from nonsubject foreign sources (i.e.,
countries other than China) changed since 2006.
We did not purchase from nonsubject foreign sources before or after the order.
No, our pattern of purchasing is essentially unchanged.
Yes, we increased purchases from nonsubject countries because of the order.
Yes, but we changed our pattern of purchases from nonsubject countries for reasons
other than the order (please explain below).

II-4.

Changes in purchasing patterns.--If the relative levels of your firm’s purchases of chloropicrin
from different sources (both domestic and foreign) have changed since 2006 (the year the
antidumping duty order under review became effective), please list the relative share from that
country has increased or decreased, and state the reason.
Source of purchases
The United States

Trend
Decreased
Increased
Constant
Fluctuated

China

Decreased
Increased
Constant
Fluctuated

All other countries

Decreased
Increased
Constant
Fluctuated

Explanation for trend

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 6

PART II.--TRADE AND RELATED INFORMATION--Continued
II-5.

Supplier identification.--Please identify below the names and addresses of your firm’s FIVE
largest suppliers for chloropicrin since 2006. Please also provide the name and telephone number
of a contact person and the share of the quantity of your firm’s total shipments of chloropicrin
that each of these customers accounted for in 2008.
Supplier’s
name

No.
1

2

3

4

5

Street address (not P.O.
box), city, state, and zip
code

Contact person

Share of
Telephone number
2008
or e-mail address purchases
(%)

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 7

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES
Further information on this part of the questionnaire can be obtained from Joshua Levy (202-205-3236,
joshua.levy@usitc.gov).
III-1.

Contact information (Market).--Who should be contacted regarding the requested market
characteristics and purchasing practices information?
Company contact:
Name and title
(
)
Phone number

III-2.

E-mail address

Firm type.--Which of the following best describes your firm as a purchaser of chloropicrin
(check all that apply, noting the specific end uses if known)?
Blender
Soil fumigation service provider
Distributor
Other (Describe:

III-3.

Competition of sales.--If you are a distributor or reseller of chloropicrin, do you compete for
sales to your customers with the manufacturers or importers from which you purchase
chloropicrin?
No

III-4.

)

Yes--Please describe

Types of customers.--If your firm is a distributor or reseller of chloropicrin, what are the major
types of consumers to which you sell chloropicrin?

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 8

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-5.

End uses.--If your firm is an end user of chloropicrin, list in order of quantity of chloropicrin
consumed, the top 3 products for which your firm purchases chloropicrin as a component part or
input. Please indicate what percentage of the total cost is accounted for by chloropicrin (and
NOTE: this percentage should not add to 100 percent).

Product(s) you produce

Share of cost accounted for by
chloropicrin (percent)

1.
2.
3.

III-6.

Demand for end use products.-(a)

If your firm is an end user of chloropicrin, has the demand for your firm’s final products
incorporating chloropicrin changed since 2006?
Increased

(b)

No change

Yes--Please describe

Changes in end uses.--Have there been any changes in the end uses of chloropicrin since 2006?
No

III-8.

Fluctuated

Has this had any effect on your firm’s demand for chloropicrin?
No

III-7.

Decreased

Yes--Please describe.

Anticipated changes in end uses.--Do you anticipate any changes in terms of the end uses of
chloropicrin in the future?
No

Yes--Please describe and identify the time period. Provide any underlying
assumptions, along with relevant portions of business plans or other
supporting documentation that address this issue.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 9

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-9.

Substitutes.--Please list in order of importance any products that may be substituted for
chloropicrin. For each possible substitute product, please give examples of applications and end
uses for which they are substitutes and indicate whether changes in the price of the substitute
affect the price for chloropicrin, and to what degree, and the length of any time lag of such an
effect.

Substitute

Description

Have changes in the prices of this
substitute affected the price for
chloropicrin?

1.

No

Yes--Please explain.

2.

No

Yes--Please explain.

3.

No

Yes--Please explain.

4.

No

Yes--Please explain.

5.

No

Yes--Please explain.

III-10. Changes in substitutes.--Have there been any changes in the number or types of products that
can be substituted for chloropicrin since 2006?
No

Yes--Please explain.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 10

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-11. Anticipated changes in substitutes.--Do you anticipate any changes in terms of the
substitutability of other products for chloropicrin in the future?
No

Yes--Please describe and provide any underlying assumptions, along with
relevant portions of business plans or other supporting documentation
that address this issue.

III-12. Demand trends.-(a)

How has the demand within the United States for chloropicrin changed since January 1,
2006? What principal factors affect changes in demand?
Increased

(b)

Decreased

Fluctuated

No change

How has the demand outside the United States (if known) for chloropicrin changed since
January 1, 2006? What principal factors affect changes in demand?
Increased

Decreased

Fluctuated

No change

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 11

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-13. Anticipated demand trends.-(a)

How do you anticipate demand will change within the United States for chloropicrin in
the future? What principal factors that will affect these changes in demand?
Increase

(b)

Decrease

Fluctuate

No change

How do you anticipate demand will change outside the United States for chloropicrin to
in the future? What principal factors that will affect these changes in demand?
Increase

Decrease

Fluctuate

No change

III-14. Market studies.--Please provide as a separate attachment to this request any studies, surveys, etc.
that you are aware of that quantify and/or otherwise discuss chloropicrin supply (including
production capacity and capacity utilization) and demand in (1) the United States, (2) each of the
other major producing/consuming countries, including China, and (3) the world as a whole. Of
particular interest is such data from 2006 to the present and forecasts for the future.
III-15. Changes in factors affecting supply.--Have any changes occurred in any other factors affecting
supply (e.g., changes in availability or prices of energy or labor; transportation conditions;
production capacity and/or methods of production; technology; export markets; or alternative
production opportunities) that affected the availability of U.S.-produced chloropicrin in the U.S.
market since 2006?
No

Yes--Please note the time period(s) of any such changes, the factors(s)
involved, and the impact such changes had on your shipment volumes
and prices.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 12

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-16. Changes in regulations.-(a)

Have any changes occurred in regulations that affect the availability of chloropicrin in the
U.S. market since 2006?
No

(b)

Yes--Please note the types of regulations, the timing of the changes in
regulations, and the impact of these regulations on your shipment
volumes and prices.

Have any changes occurred in regulations that affect the demand for chloropicrin in the
U.S. market since 2006?
No

Yes-- Please note the types of regulations, the timing of the changes
in regulations, and the impact of these regulations on your shipment
volumes and prices.

III-17. Shortages, allocations, and supply disruptions.—Has your firm had any problems acquiring an
adequate supply of chloropicrin (shortages, allocations or supply disruptions) since 2006?
No

Yes--Please note the time period(s) of any such changes, the factors(s)
involved, and the impact such supply problems had on your firm.

III-18. Is buying a product that is produced in the United States an important factor in your firm’s
purchases of chloropicrin (please check ALL that apply)?
No
Yes--Purchases of domestic product are required by law or regulation (for example,
government purchases under “Buy American” provisions). This involves
percent of
all purchases of chloropicrin.
Yes--Purchases of domestic product are not required by law or regulation, but are by your
customers. This involves
percent of all purchases of chloropicrin.
Yes--Purchases of domestic product are required for other reasons (please specify these
reasons below). This involves
percent of all purchases of chloropicrin.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 13

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-19. Conditions of competition.-(a)

Is the chloropicrin market subject to business cycles or conditions of competition
distinctive to chloropicrin?
No

(b)

Yes--Please explain and provide estimates of the duration of any such
cycle.

Has the emergence of new markets for chloropicrin since 2006 affected the business
cycles or conditions of competition distinctive to chloropicrin?
No

Yes--Please explain any such changes.

III-20. Decisions based on producer.--Does your firm, and to the extent that you know, do your
customers make purchasing decisions involving chloropicrin based on the producer of the
chloropicrin you purchase?
Your firm:

Always

Usually

Sometimes

Never

Your customers:

Always

Usually

Sometimes

Never

If at least sometimes, please discuss how your firm or your customers determine the producer and
why this information is important.
Your firm:

Your customers:

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 14

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-21. Decisions based on country-of-origin.--Does your firm, and to the extent that you know, do
your customers make purchasing decisions involving chloropicrin based on the country of origin
of the chloropicrin you purchase?
Your firm:

Always

Usually

Sometimes

Never

Your customers:

Always

Usually

Sometimes

Never

If at least sometimes, please discuss how your firm or your customers determine the source and
why this information is important.
Your firm:

Your customers:

III-22. Purchasing frequency.-(a)

How frequently do you make purchases?
Daily
Weekly
Monthly
Quarterly
Annually
Other (specify)

(b)

)

Do you expect this purchasing pattern to change in the next two years?
No

Yes-- How and why do you expect these changes to occur?

III-23. Number of suppliers contacted.--How many suppliers do you generally contact before making a
purchase?

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 15

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-24. Supplier negotiations.-(a)

Do purchases of chloropicrin usually involve negotiations between supplier and
purchaser?
No

(b)

Yes--Please describe these negotiations. In your response, please
comment on whether purchasers generally quote competing
prices as part of the negotiation process.

Does your firm tend to vary its purchases from a given supplier within a specified time
period based on the price offered for that period?
No

Yes--Specify the time period.

III-25. Change in suppliers.--Have you changed suppliers since 2006?
No

Yes--Please list the supplier or suppliers and indicate whether the firm was
added or dropped as a supplier. Also give the reasons for the change
and how frequently you change suppliers.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 16

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-26. New suppliers.-(a)

Are you aware of any new suppliers, either foreign or domestic, that have entered the
market since 2006?
No

(b)

Yes--Please identify the firms and indicate how you became aware of
them.

Do you expect new chloropicrin suppliers to enter the market in the future?
No

Yes--Please provide details, noting the specific future time period in
your response.

III-27. Supplier qualification.--Do you require your suppliers to become certified or prequalified with
respect to the quality, chemistry, strength, or other performance characteristic of the chloropicrin
they sell to your firm?
No

Yes--

percent of purchases in 2008

Yes--all purchases

Please provide a general description of the certification or qualification process and the time
required.

III-28. Factors considered vis-à-vis suppliers.--Briefly describe the factors that you consider when
qualifying a new supplier (e.g., quality of product, reliability of supplier, etc.) and estimate the
time it takes to certify or qualify a new supplier.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 17

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-29. Failure to certify.--Since 2006, have any domestic or foreign producers failed in their attempts to
certify or qualify their chloropicrin with your firm or have any producers lost their approved
status?
No

Yes--Please identify these firms, the countries where they are located, and the
reasons why they failed the certification/qualification.

III-30. Purchasing factors.--For the factors listed below, please rate each in terms of its importance in
your purchase decision for chloropicrin.
Very
important
Availability .......................................
Contamination (lack of) ...................
Delivery terms .................................
Delivery time ...................................
Discounts offered ............................
Extension of credit...........................
Price ................................................
Minimum qty requirements..............
Packaging .......................................
Product consistency ........................
Quality meets industry standards....
Quality exceeds industry standards
Product range..................................
Reliability of supply .........................
Technical support/service ...............
U.S. transportation costs.................
Other (specify):
........
........

Somewhat
important

Not
important

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 18

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-31. Major purchasing factors.--Please list, in order of their importance, the three major factors
generally considered by your firm in deciding from whom to purchase chloropicrin for any one
order (examples include current availability, extension of credit, prearranged contracts, price,
quality exceeding specifications or industry standards, range of supplier’s product line, traditional
supplier, etc.).
1.
2.
3.
Other factors or comments:

III-32. Quality characteristics.--What characteristics does your firm consider when determining the
quality of chloropicrin?

III-33. Choice of product not based on price.--If you purchased chloropicrin from one source although
a comparable product was available from another source at a lower price, please explain your
reasons for doing so (please specify by country, including the United States and both subject and
nonsubject foreign countries). Possibilities might include transaction characteristics such as
length of time to fill orders, minimum order size, reliability of supply, etc.

III-34. Frequency of decisions based on price.--How often does your firm purchase the chloropicrin
that is offered at the lowest price?
Always

Usually

Sometimes

Never

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 19

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-35. Price leaders.--Please list the names of any firms you considered price leaders in the chloropicrin
market since 2006. A price leader is defined as (1) one or more firms that initiate a price change,
either upward or downward, that is followed by other firms, or (2) one or more firms that have a
significant impact on prices. A price leader does not necessarily have to be the lowest priced
supplier. For those firms identified as a price leader, please specify the time period in which a
price change was communicated, whether the price change was upward or downward, and
whether it covered a specific geographic region or a specific product type.

III-36. Frequency of price changes.--How frequently does the price of the chloropicrin you are
purchasing change?

III-37. Changes in U.S. industry.-(a)

Please identify and discuss any improvements/changes in the U.S. chloropicrin industry
since 2006 and explain fully, to the extent possible, the factor(s), including the order(s)
under review, that was/(were) responsible for each improvement/change.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 20

PART III.-- MARKET CHARACTERISTICS AND PURCHASING PRACTICES--Continued
III-38. Changes in U.S. industry.--Continued
(b)

Please also discuss fully, to the extent possible, any improvements/changes that you
anticipate in the future in the U.S. chloropicrin industry. Identify the specific future time
period covered in your response, and discuss the factors that you believe would be
responsible for each improvement/change.

III-39. Effect of revocation.--What do you think will be the likely effects of any revocation of the
antidumping duty order for imports of chloropicrin from China? As appropriate, please discuss
any potential effects of revocation of the antidumping duty order on (1) the future activities of
your firm and (2) the U.S. market as a whole. Please note the future time period to which you are
referring. Attach additional pages if necessary.
(1) Activities of your firm:

(2) Entire U.S. market:

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin

Page 21

PART IV.-- PRODUCT COMPARISIONS
Further information on this part of the questionnaire can be obtained from Joshua Levy (202-205-3236,
joshua.levy@usitc.gov).
IV-1.

Contact information (Product Comparisons).--Who should be contacted regarding the
requested production comparison information?
Company contact:
Name and title
(
)
Phone number

IV-2.

E-mail address

Country knowledge.--Please indicate the countries of origin for chloropicrin for which your firm
has actual marketing/pricing knowledge.
United States
China
Other countries (Please specify

IV-3.

)

Interchangeability by country-pair.--Is chloropicrin produced in the United States and in other
countries interchangeable (i.e., can they physically be used in the same applications)? Please
indicate below, using “A” to indicate that the products from a specified country-pair are always
interchangeable, “F” to indicate that the products are frequently interchangeable, “S” to indicate
that the products are sometimes interchangeable, “N” to indicate that the products are never
interchangeable, and “0” to indicate no familiarity with products from a specified country-pair.1
Country-pair

China

Other countries

United States
China
1

For any country-pair producing chloropicrin which is sometimes or never interchangeable, please
explain the factors that limit or preclude interchangeable use:

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin

Page 22

PART IV.-- PRODUCT COMPARISIONS--Continued
IV-4.

Country preferences.--Do you or your customers ever specifically order chloropicrin from one
country in particular over other possible sources of supply?
No

IV-5.

Yes--Please identify all relevant countries (including the United States and
both subject and nonsubject foreign countries) from which you or your
customers prefer to order, and indicate why chloropicrin from these
countries is preferred over product from other countries (please note
the specific product in your response).

Availability of merchandise.--Are certain grades/types/sizes of chloropicrin available from only
a single source (domestic or foreign, including both China and nonsubject countries)?
No

Yes--Please identify the source and the grade/type/size.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin

Page 23

PART IV.-- PRODUCT COMPARISIONS--Continued
Factor country comparisons.--For the factors listed below, please rate how chloropicrin
produced in each country you identified in your response to the first question in Part IV compares
with chloropicrin produced in each of the other countries you identified (including the United
States and both subject and nonsubject foreign countries).

Availability ...............................................
Contamination (lack of) ...................
Delivery time ...........................................
Discounts offered ....................................
Extension of credit...................................
Price1 .......................................................
Minimum quantity requirements..............
Packaging ...............................................
Product consistency ................................
Quality meets industry standards............
Quality exceeds industry standards ........
Product range..........................................
Reliability of supply .................................
Technical support/service .......................
U.S. transportation costs1 .......................
Other (specify):

Inferior

Comparable

product from
China
compared to
product from
Nonsubject
countries

Superior

Inferior

product from
U.S.
compared to
product from
nonsubject
countries
Comparable

Inferior

Comparable

Quality

Superior

product from
U.S.
compared to
product from
China

Superior

IV-6.

Business Proprietary
U.S. Purchasers’ Questionnaire - Chloropicrin

Page 24

PART IV.-- PRODUCT COMPARISIONS--Continued
IV-7.

Minimum quality.-(a)

How often does domestically produced chloropicrin meet minimum quality specifications
for your uses or your customers’ uses?
Always

(b)

Usually

Sometimes

Rarely or never

How often does imported subject chloropicrin meet minimum quality specifications for
your uses or your customers’ uses?

Source

Always

Usually

Sometimes

Rarely or
never

China

(c)

How often does imported nonsubject chloropicrin (i.e., chloropicrin from countries other
than China) meet minimum quality specifications for your uses or your customers’ uses?
Source

IV-8.

Always

Usually

Sometimes

Rarely or
never

Change in price.-(a)

Since 2006, has there been a change in the price of chloropicrin? If so, has the price of
U.S.-produced chloropicrin changed more or less than the price of imported chloropicrin
from China?
No change in price
Prices have changed by the same amount
Price of U.S.-produced chloropicrin has changed relative to the price of chloropicrin
from China

(b)

If the price of U.S.-produced chloropicrin has changed relative to the price of
chloropicrin from China, the price of U.S.-produced chloropicrin is now relatively
Higher

Lower